Inventor · disambiguated record
Nicholas F. Landolfi
Also filed as: LANDOLFI NICHOLAS F
19 granted patents·7 pending applications·6,513 citations·filing 1993–2019
96Inventor score
Files withPROTEIN DESIGN LABS INC7WILLIAMS MARNA6PDL BIOPHARMA INC4ABBOTT BIOTHERAPEUTICS CORP3ABBVIE BIOTHERAPEUTICS INC3
Top patents by PatentIndex Score
26 records- 0198US6329511B1Humanized antibodies to γ-interferonPROTEIN DESIGN LABS INC·Filed 1999·Granted Dec 11, 2001·308 cites·8 claims
- 0298US5693762AHumanized immunoglobulinsPROTEIN DESIGN LABS INC·Filed 1995·Granted Dec 2, 1997·5.3k cites·20 claims
- 0398US5349053AChimeric ligand/immunoglobulin molecules and their usesPROTEIN DESIGN LABS INC·Filed 1993·Granted Sep 20, 1994·590 cites·12 claims
- 0497US8008450B2Therapeutic use of anti-CS1 antibodiesABBOTT BIOTHERAPEUTICS CORP·Filed 2009·Granted Aug 30, 2011·64 cites·4 claims
- 0593US7709610B2Therapeutic use of anti-CS1 antibodiesFACET BIOTECH CORP·Filed 2004·Granted May 4, 2010·40 cites·26 claims
- 0693US5882644AMonoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereofPROTEIN DESIGN LABS INC·Filed 1996·Granted Mar 16, 1999·121 cites·13 claims
- 0791US9028830B2Antibodies to CD122TSO J YUN·Filed 2011·Granted May 12, 2015·21 cites·13 claims
- 0890US8461306B2Therapeutic use of anti-CS1 antibodiesWILLIAMS MARNA·Filed 2011·Granted Jun 11, 2013·10 cites·19 claims
- 0988US8445646B2Therapeutic use of anti-CS1 antibodiesWILLIAMS MARNA·Filed 2011·Granted May 21, 2013·8 cites·16 claims
- 1088US8444980B2Therapeutic use of anti-CS1 antibodiesWILLIAMS MARNA·Filed 2011·Granted May 21, 2013·8 cites·40 claims
- 1188US8349330B2Therapeutic use of anti-CS1 antibodiesABBOTT BIOTHERAPEUTICS CORP·Filed 2011·Granted Jan 8, 2013·8 cites·16 claims
- 1288US8088898B2Therapeutic use of anti-CS1 antibodiesWILLIAMS MARNA·Filed 2009·Granted Jan 3, 2012·7 cites·9 claims
- 1387US8436146B2Therapeutic use of anti-CS1 antibodiesWILLIAMS MARNA·Filed 2011·Granted May 7, 2013·7 cites·18 claims
- 1487US8133981B2Therapeutic use of anti-CS1 antibodiesWILLIAMS MARNA·Filed 2009·Granted Mar 13, 2012·6 cites·16 claims
- 1584US7223393B2Amphiregulin antibodies and their use to treat cancer and psoriasisPDL BIOPHARMA INC·Filed 2004·Granted May 29, 2007·16 cites·6 claims
- 1679US9175081B2Therapeutic use of anti-CS1 antibodiesABBVIE BIOTHERAPEUTICS INC·Filed 2013·Granted Nov 3, 2015·2 cites·36 claims
- 1779US7935793B2Treatment of inflammatory bowel diseases with anti-IP-10 antibodiesABBOTT BIOTHERAPEUTICS CORP·Filed 2004·Granted May 3, 2011·17 cites·12 claims
- 1878US7183390B2Humanized antibodies to gamma-interferonPDL BIOPHARMA INC·Filed 2001·Granted Feb 27, 2007·9 cites·12 claims
- 1969US2020031929A1Therapeutic use of anti-cs1 antibodiesABBVIE BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2061US10442859B2Therapeutic use of anti-CS1 antibodiesABBVIE BIOTHERAPEUTICS INC·Filed 2015·Granted Oct 15, 2019·0 cites·12 claims
- 2160US2008160018A1Humanized immunoglobulinsPDL BIOPHARMA INC·Filed 2006·Application pending·0 cites
- 2259US2005025763A1Therapeutic use of anti-CS1 antibodiesPROTEIN DESIGN LABS INC·Filed 2004·Application pending·0 cites
- 2355US2003229208A1Humanized immunoglobulinsPROTEIN DESIGN LABS INC·Filed 2003·Application pending·0 cites
- 2455US2008226632A1Amphiregulin antibodies and their use to treat cancer and psoriasisPDL BIOPHARMA INC·Filed 2007·Application pending·0 cites
- 2555US2004058414A1Humanized immunoglobulinsFiled 2003·Application pending·0 cites
- 2655US2004049014A1Humanized immunoglobulinsPROTEIN DESIGN LABS INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas F. Landolfi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →